| 000 | 01756 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513110055.0 | ||
| 264 | 0 | _c19970124 | |
| 008 | 199701s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diab.46.1.51 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCivelek, V N | |
| 245 | 0 | 0 |
_aOscillations in oxygen consumption by permeabilized clonal pancreatic beta-cells (HIT) incubated in an oscillatory glycolyzing muscle extract: roles of free Ca2+, substrates, and the ATP/ADP ratio. _h[electronic resource] |
| 260 |
_bDiabetes _cJan 1997 |
||
| 300 |
_a51-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 | _aCell Membrane Permeability |
| 650 | 0 | 4 | _aClone Cells |
| 650 | 0 | 4 |
_aEgtazic Acid _xpharmacology |
| 650 | 0 | 4 |
_aFructosediphosphates _xpharmacology |
| 650 | 0 | 4 |
_aGlycerophosphates _xpharmacology |
| 650 | 0 | 4 | _aGlycolysis |
| 650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xphysiology |
| 650 | 0 | 4 |
_aNAD _xmetabolism |
| 650 | 0 | 4 | _aOscillometry |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 |
_aPyruvic Acid _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSpectrometry, Fluorescence |
| 650 | 0 | 4 |
_aThapsigargin _xpharmacology |
| 700 | 1 | _aDeeney, J T | |
| 700 | 1 | _aFusonie, G E | |
| 700 | 1 | _aCorkey, B E | |
| 700 | 1 | _aTornheim, K | |
| 773 | 0 |
_tDiabetes _gvol. 46 _gno. 1 _gp. 51-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diab.46.1.51 _zAvailable from publisher's website |
| 999 |
_c8962815 _d8962815 |
||